Contrasting contributions of TNF from distinct cellular sources in arthritis

OBJECTIVES: Neutralisation of tumour necrosis factor (TNF) is widely used as a therapy for rheumatoid arthritis (RA). However, this therapy is only effective in less than a half of patients and is associated with several side effects. We hypothesised that TNF may possess non-redundant protective and...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ann Rheum Dis
Autors principals: Kruglov, Andrey, Drutskaya, Marina, Schlienz, Dirk, Gorshkova, Ekaterina, Kurz, Katharina, Morawietz, Lars, Nedospasov, Sergei
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2020
Matèries:
Rheumatoid Arthritis
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7569389/
https://ncbi.nlm.nih.gov/pubmed/32796044
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2019-216068
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars